Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.
Hi Lotm-13,
Apologies for belated response - been a bit poorly.
No, the IMP shares no longer listed in my ISA. Instead the Heather and Tapir shares are listed in my share dealing account, but with no values. No information on when/if those shares can be traded but it seems unlikely that any proceeds could be credited to ISA (although I suppose they could be bed-and-ISA in another tax year).
Just a received Corporate Action note from broker confirming that Heather and Tapir cannot be held in ISA and will be transferred to my share dealing account. I guess that when they are listed on a market, it may then be possible to transfer into an ISA.
The 50% reduction of dividend was not unexpected but I was in for the income, so I've taken advantage of the 3% rise in SP to get out whilst I'm still ahead. The premium from a merger offer would have been welcome, but bird in the hand and all that. Good luck to you all.
"AMSTERDAM, Dec 15 (Reuters) - A court in the Netherlands on Friday ordered British American Tobacco to pay a fine of 107 million euros ($117 million), and said it owed back taxes on 1.8 billion euros in profit."
DYOR etc.
Best wishes all
Ademcg
Agreed.
Although I usually invest for the medium/long term rather than trade, I try to cut any losses at 7-8%. Unfortunately, sometimes they take the elevator down and hit -20 or worse before I can place a sell! I might then hold for a while in hope of a recovery, but I rarely double down.
I think it may be more to do with the fundamental differences between US businesses and markets and those in the UK (or at least FTSE 100). According to an old friend on Wall St, US investors focus on returns through growth and signs of reduced investment in the business tend to be punished. A company that prioritises investment for growth over distributing dividends is more likely to achieve a better valuation in the US than in UK. A company that fails to identify growth opportunities and so distributes excess to shareholders is more likely to be appreciated in UK.
I guess the wide variation in target prices depends upon the valuations the analysts are using for their discount cash flow models. The cuts to production and capex will dampen potential future growth - but by how much? If you suspect it will limit AAL's opportunities to benefit from future commodity price increases, then your target price likely would be below its competitors.
Hope you're correct about a bounce but I don't see much sign of one yet, or any squeeze on shorts. As a long-term investor, I'm concerned that the reduced capex will adversely affect future growth and earnings. That would inevitably pull down the SP. Just hope we're not staring at a 'new normal'!